Early-onset leukoencephalopathy due to a homozygous missense mutation in the DARS2 gene

Documents

  • Cornelia Köhler
  • Christoph Heyer
  • Sabine Hoffjan
  • Susanne Stemmler
  • Thomas Lücke
  • Charlotte Thiels
  • Alfried Kohlschütter
  • Ulrike Löbel
  • Rita Horvath
  • Stephanie Kleinle
  • Anna Benet-Pagès
  • Angela Abicht

Abstract

Mutations in the DARS2 gene are known to cause leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL), a rare autosomal recessive neurological disorder. It was originally described as juvenile-onset slowly progressive ataxia and spasticity, but recent reports suggest a broader clinical spectrum. Most patients were found to carry compound heterozygous DARS2 mutations, and only very few patients with homozygous mutations have been described so far. We present here an 8-month-old boy carrying a homozygous missense mutation in DARS2 who clinically showed severe neurological deterioration after a respiratory tract infection, followed by an almost complete remission of symptoms. This report further extends the knowledge about the clinical and molecular genetic spectrum of LBSL.

Bibliographical data

Original languageEnglish
ISSN0890-8508
DOIs
Publication statusPublished - 29.10.2015